oa Current Allergy & Clinical Immunology - Allergy immunotherapy update - review

Volume 32 Number 2
  • ISSN : 1609-3607



Allergy immunotherapy has recently been reviewed and the latest recommendations were published by the European Academy of Allergy and Clinical Immunology in 2018. This article summarises these recommendations. This therapy is an effective form of treatment for allergic conditions such as allergic rhinoconjunctivitis, allergic asthma, and bee and wasp hypersensitivity. A formal diagnosis of an allergy (ie the presence of both a convincing clinical picture and confirmation through skin-prick testing or allergen-specific IgE), is necessary for allergy immunotherapy to be initiated. Patients should be considered on a case-by-case basis, with various factors being examined prior to this therapy: their current allergy treatment, compliance, long-term treatment goals and co-morbid health problems. Standardised allergy immunotherapy products administered at regulated doses is the current recommendation and long-term allergy protection is possible with extended treatment. Allergy immunotherapy for food allergies is subject to extensive research, the latest guidelines suggesting that this should be administered only within research settings at this stage. In cases of atopic dermatitis, this therapy has its place in the treatment of aeroallergens. South Africa has a number of standardised allergy immunotherapy products available which are used countrywide. The most common allergens treated in South Africa are grass, house-dust mite and hymenoptera bee stings

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error